|
|
| | Sitagliptin EP Impurity C Basic information |
| Product Name: | Sitagliptin EP Impurity C | | Synonyms: | Sitagliptin Defuoro IMpurity 2;Sitagliptin impurity 40/5-Desfluoro Sitagliptin/(R)-3-amino-4-(2,4-difluorophenyl)-1-(3-(trifluoromethyl)-5,6- dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)butan-1-one;Sitagliptin-6;(R)-3-amino-4-(2,4-difluorophenyl);1-Butanone, 3-amino-4-(2,4-difluorophenyl)-1-[5,6-dihydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazin-7(8H)-yl]-, (3R)-;Sitagliptin Impurity 16 (Sitagliptin EP Impurity C);Sitagliptin phosphate impurity E;Sitagliptin 2,4-Difluoro Analogue | | CAS: | 945261-48-3 | | MF: | C16H16F5N5O | | MW: | 389.32 | | EINECS: | | | Product Categories: | | | Mol File: | 945261-48-3.mol |  |
| | Sitagliptin EP Impurity C Chemical Properties |
| Boiling point | 531.8±60.0 °C(Predicted) | | density | 1.56±0.1 g/cm3(Predicted) | | pka | 7.79±0.10(Predicted) |
| | Sitagliptin EP Impurity C Usage And Synthesis |
| Uses | 5-Desfluoro Sitagliptin is a Sitagliptin impurity (S491000). Sitagliptin is a trizolopyrazine dipeptidyl peptidase IV inhibitor. Sitagliptin has recently been approved for the therapy of type II diabetes. |
| | Sitagliptin EP Impurity C Preparation Products And Raw materials |
|